Status:
COMPLETED
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Lead Sponsor:
Spectranetics Corporation
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
Brief Summary
A retrospective study to evaluate Turbo Power laser atherectomy + drug coated balloon (DCB) angioplasty for the treatment of femoropopliteal de novo/restenotic lesions and in-stent restenosis (ISR).
Eligibility Criteria
Inclusion
- All patients treated for femoropopliteal de novo/restenotic lesions or in-stent restenosis using Turbo Power laser atherectomy plus drug coated balloon angioplasty
Exclusion
- Any incomplete data on procedural approach and treatment
Key Trial Info
Start Date :
October 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2018
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT03306199
Start Date
October 3 2017
End Date
June 5 2018
Last Update
April 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Institute of the South
Houma, Louisiana, United States, 70360